Inventor
Brendan Mark JOHNSON
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,336,990Treatment of prostate cancer202512,144,809Treatment of prostate cancer202412,097,198Treatment of prostate cancer202411,957,684Treatment of heavy menstrual bleeding associated with uterine fibroids202411,793,812Methods of treating endometriosis202311,638,740Methods of treating female infertility202311,583,526Treatment of prostate cancer2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (6)· patent assignee history
2023–2025Patents assigned to SUMITOMO PHARMA SWITZERLAND GMBH (5)· patent assignee history
2023Patents assigned to MYOVANT SCIENCES GMBH (2)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 6 | 2023–2025 |
| SUMITOMO PHARMA SWITZERLAND GMBH | 5 | 2023–2025 |
| MYOVANT SCIENCES GMBH | 2 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2023–2025 |